{"text": ["AbbVie", "Missed", "Revenue", "Estimates", "in", "Q4", "2018"], "created_at": "2019-01-28 22:25:18"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/28/2019:", "ABBV,ALXN,TRVN,ARAY"], "created_at": "2019-01-28 21:23:01"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/28/2019:", "ABBV,ALXN,TRVN,ARAY"], "created_at": "2019-01-28 21:23:01"}
{"text": ["What", "Are", "Analysts", "Recommending", "for", "AbbVie", "after", "Q4", "2018", "Results?"], "created_at": "2019-01-28 20:52:46"}
{"text": ["Monday", "Sector", "Laggards:", "Energy,", "Healthcare"], "created_at": "2019-01-28 20:43:02"}
{"text": ["Monday", "Sector", "Laggards:", "Energy,", "Healthcare"], "created_at": "2019-01-28 20:43:02"}
{"text": ["Drug/Biotech", "Stock", "Earnings", "on", "Jan", "29:", "PFE,", "AMGN,", "BIIB", "&", "AGN"], "created_at": "2019-01-28 17:48:24"}
{"text": ["Drug/Biotech", "Stock", "Earnings", "on", "Jan", "29:", "PFE,", "AMGN,", "BIIB", "&", "AGN"], "created_at": "2019-01-28 17:48:24"}
{"text": ["Is", "AbbVie", "in", "Hot", "Water?"], "created_at": "2019-01-28 17:10:20"}
{"text": ["This", "is", "Why", "AbbVie", "(ABBV)", "is", "a", "Great", "Dividend", "Stock"], "created_at": "2019-01-28 16:54:11"}
{"text": ["This", "is", "Why", "AbbVie", "(ABBV)", "is", "a", "Great", "Dividend", "Stock"], "created_at": "2019-01-28 16:54:11"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "J&J,", "Bristol-Myers,", "Lilly,", "AbbVie", "and", "Merck"], "created_at": "2019-01-28 16:49:44"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "J&J,", "Bristol-Myers,", "Lilly,", "AbbVie", "and", "Merck"], "created_at": "2019-01-28 16:49:44"}
{"text": ["Analysts", "Cut", "AbbVie", "Price", "Targets", "After", "Earnings", "Miss"], "created_at": "2019-01-28 15:59:44"}
{"text": ["5", "Dividend", "Growth", "Stocks", "With", "Upside", "To", "Analyst", "Targets"], "created_at": "2019-01-28 15:44:36"}
{"text": ["5", "Dividend", "Growth", "Stocks", "With", "Upside", "To", "Analyst", "Targets"], "created_at": "2019-01-28 15:44:36"}
{"text": ["Drug/Biotech", "Stock", "Earnings", "on", "Jan", "29:", "PFE,", "AMGN,", "BIIB", "&", "AGN"], "created_at": "2019-01-28 15:19:03"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "J&J,", "Bristol-Myers,", "Lilly,", "AbbVie", "and", "Merck"], "created_at": "2019-01-28 15:07:03"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/28/2019:", "TRVN,", "ARAY,", "ABBV,", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN"], "created_at": "2019-01-28 14:43:59"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/28/2019:", "TRVN,", "ARAY,", "ABBV,", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN"], "created_at": "2019-01-28 14:43:59"}
{"text": ["This", "is", "Why", "AbbVie", "(ABBV)", "is", "a", "Great", "Dividend", "Stock"], "created_at": "2019-01-28 14:15:02"}
{"text": ["AbbVie", "Announces", "U.S.", "FDA", "Approval", "of", "IMBRUVICA\u00ae", "(ibrutinib)", "Plus", "Obinutuzumab", "(GAZYVA\u00ae)", "-", "First", "Chemotherapy-Free,", "Anti-CD20", "Combination", "Regimen", "Approved", "for", "Chronic", "Lymphocytic", "Leukemia/Small", "Lymphocytic", "Lymphoma", "(CLL/SLL)", "in", "Previously", "Untreated", "Patients"], "created_at": "2019-01-28 12:00:00"}
{"text": ["AbbVie", "Falls", "3%"], "created_at": "2019-01-28 10:38:02"}
{"text": ["What's", "Making", "News", "In", "These", "Pharma", "And", "Cannabis", "Stocks", "Today?"], "created_at": "2019-01-28 09:00:00"}
{"text": ["What's", "Making", "News", "In", "These", "Pharma", "And", "Cannabis", "Stocks", "Today?"], "created_at": "2019-01-28 09:00:00"}
{"text": ["3", "Reasons", "AbbVie", "Investors", "Aren't", "Too", "Worried", "About", "Humira", "Anymore"], "created_at": "2019-01-28 01:43:10"}
{"text": ["3", "Reasons", "AbbVie", "Investors", "Aren't", "Too", "Worried", "About", "Humira", "Anymore"], "created_at": "2019-01-28 01:43:10"}
{"text": ["3", "Reasons", "AbbVie", "Investors", "Aren&apos;t", "Too", "Worried", "About", "Humira", "Anymore"], "created_at": "2019-01-28 00:16:00"}
